Rallis India Limited (NSE: RALLIS | BSE: 500355)
Source: Rallis India Limited Integrated Annual Report 2025-26 (Fiscal Year Ended March 31, 2026)
📋 Quick Facts: Company Snapshot
Rallis India Limited, a flagship agricultural solutions enterprise of the Tata Group and a subsidiary of Tata Chemicals Limited, is one of India’s premier integrated crop care and seed companies. Operating across the complete agricultural value chain, Rallis provides science-led solutions spanning Crop Care (herbicides, insecticides, fungicides), Soil & Plant Health (bio-fertilisers, bio-stimulants, bio-pesticides), and high-yielding Hybrid Seeds under its renowned ‘Dhaanya’ brand. With over 77 years of operational presence in rural India, the Company serves millions of farmers across 26 States and Union Territories covering approximately 80% of Indian agricultural districts, while expanding its export footprint across 30+ international markets.
| Attribute | Disclosed Detail |
|---|---|
| Official Company Name | Rallis India Limited |
| Corporate Identity Number (CIN) | L36992MH1948PLC014083 |
| International Securities Identification Number (ISIN) | INE613A01020 |
| NSE Symbol & BSE Scrip Code | NSE: RALLIS | BSE: 500355 |
| Date of Incorporation / Founding Legacy | Incorporated on August 23, 1948 (Historical merchant origins trace back to 1810s / 1851 entry in India) |
| Registered Office & Corporate Headquarters | 23rd Floor, Vios Tower, New Cuffe Parade, Off Eastern Freeway, Wadala, Mumbai – 400 037, Maharashtra, India |
| Telephone & Investor Relations Contact | Tel: +91 22 6232 7400 | E-mail: investor_relations@rallis.com |
| Chairman of the Board | S. Padmanabhan (Non-Executive, Non-Independent Director) |
| Managing Director & CEO | Dr. Gyanendra Shukla |
| Chief Financial Officer (CFO) | Bhaskar Swaminathan (Effective August 7, 2025) |
| Company Secretary & Compliance Officer | Sariga P. Gokul (Effective May 9, 2025) |
| Promoter & Parent Holding Entity | Tata Chemicals Limited (Tata Group) — Holds 55.04% Equity Stake |
| Industry & Sector Classification | Agri-Inputs / Agrochemicals, Bio-inputs & Hybrid Seeds |
| Total Permanent & Extended Workforce | 1,540 Permanent Workforce (1,518 Employees & 22 Workers); Total On-Roll & Contractual Workforce: 5,546 |
| Manufacturing & Processing Facilities | 5 Agrochemical Plants (Akola, Ankleshwar, Lote, Dahej SEZ, Dahej CZ), 10 Third-Party Facilities, 2 Seed Processing Facilities |
| Geographical Footprint & Network | 26 Indian States & UTs (~80% District Coverage); Global Export Presence in 30+ Countries |
| Statutory Auditors | B S R & Co. LLP, Chartered Accountants (Firm Registration No. 101248W/W-100022) |
| Registrar & Share Transfer Agent (RTA) | MUFG Intime India Private Limited (formerly Link Intime India Private Limited) |
🏢 The Corporate Identity: Who They Are & Where They Came From
The Big Picture
Rallis India Limited stands as an essential pillar of India’s agricultural ecosystem, delivering science-driven inputs and agronomic solutions that nurture the land and nourish rural livelihoods. As a subsidiary of Tata Chemicals Limited, Rallis combines the institutional trust of the Tata Group with specialized agronomic expertise, operating across three core product verticals: Crop Care (Crop Protection chemistries), Soil & Plant Health (biologicals and specialty plant nutrition), and Seeds (hybrid germplasm). The Company operates an integrated business model spanning basic research, formulation chemistry, molecular plant breeding, state-of-the-art manufacturing, automated seed processing, and an extensive distribution network.
In FY 2025-26, Rallis demonstrated operational momentum by delivering ₹ 2,896.65 crore in Revenue from Operations and generating ₹ 183.88 crore in Net Profit After Tax. The Company’s manufacturing backbone comprises five high-capacity agrochemical facilities in Maharashtra and Gujarat, alongside two modern seed processing and cob-drying hubs in Telangana. Through a robust distribution ecosystem of over 4,662 Crop Care dealers, 2,600 Seeds dealers, and a network of 95,000+ retail touchpoints, Rallis empowers approximately 8.66 million farmers across India’s agro-climatic zones while delivering customized technical inputs and contract manufacturing (CSM) services to multinational clients worldwide.
- Revenue Scale: Consolidated Revenue from Operations expanded by 8.78% year-on-year to reach ₹ 2,896.65 crore in FY 2025-26 compared to ₹ 2,662.94 crore in FY 2024-25.
- Profitability & Margins: EBITDA reached ₹ 360.98 crore (12.46% margin), while Profit After Tax surged by 46.95% to ₹ 183.88 crore.
- Zero External Net Debt: Maintained an exceptionally strong balance sheet with zero net external debt, backed by ₹ 2,042.97 crore in Total Equity and robust cash conversion.
- Domestic & Export Mix: Domestic agricultural business generated 77.9% of total revenues, while global exports across 30+ countries contributed 22.1%.
The Founders, Promoters & Their Legacy
The institutional origins of Rallis trace back over two centuries to the Greek merchant enterprise “House of Ralli,” established by the Ralli Brothers in the early 1810s. Entering India in 1851, Ralli Brothers initially established commodity trading operations in Calcutta and Bombay, expanding into full-pressed jute bales, opium, silk, turmeric, grain, and general merchandise. Following structural reorganizations across London and Indian management, Rallis India Limited was formally incorporated in India on August 23, 1948, marking its transformation into an Indian corporate entity focused on agrochemicals, engineering, and fertilisers.
The Tata Group entered Rallis as a principal shareholder alongside Fisons during the mid-20th century, eventually consolidating its ownership through Tata Chemicals Limited. Today, Tata Chemicals Limited holds a 55.04% equity stake in Rallis India Limited (with promoter group total holding at 55.08%). Under the leadership philosophy of ‘Leadership with Trust’, Rallis aligns its strategic, environmental, and governance objectives with the broader Tata Group vision, including the Aalingana decarbonization framework and the Tata Business Excellence Model (TBEM).
The Journey: History & Evolution
Over its 77-year post-incorporation journey, Rallis underwent multiple structural recalibrations to evolve from a commodity trader and engineering enterprise into an exclusive agricultural solutions powerhouse. During the 1980s and 1990s, Rallis exited non-core engineering and cotton trading operations to concentrate capital on agrochemicals and specialty crop nutrition, establishing major technical synthesis and formulation facilities across Lote, Ankleshwar, Akola, and Dahej.
The 2010s marked a transformative expansion into plant genetics with the acquisition of Metahelix Life Sciences Limited, a premier research-driven seed enterprise. This strategic move established Rallis’ Seeds Division and birthed the ‘Dhaanya’ brand. Subsequent amalgamations of Metahelix Life Sciences Limited and Zero Waste Agro Organics Limited (producers of patented GEOGREEN® organic manure) streamlined Rallis into a single, cohesive corporate entity. In recent years, Rallis launched its open-innovation initiative Idea2Impact™, commercialized water-soluble bio-stimulants under the NuCode™ platform, and established multi-purpose plant (MPP) capacities at the Dahej Special Economic Zone (SEZ).
The Corporate Umbrella
Rallis operates as a direct listed subsidiary of Tata Chemicals Limited within the Tata Group’s chemical and industrial business cluster. The corporate architecture is streamlined: Rallis India Limited has no active subsidiaries, associates, or joint venture entities as of March 31, 2026, following the prior complete amalgamation of its erstwhile subsidiaries. The entire business execution—spanning agrochemicals, biologicals, seeds breeding, and global custom synthesis—is managed directly through the single corporate entity of Rallis India Limited.
⚙️ The Business Engine: What They Do & Where They Operate
The Core Divisions
Rallis structures its primary reporting operations under two principal Ind AS 108 segments: Agri Inputs and Others. The Agri Inputs segment represents 99.30% of total revenue from operations and encompasses Crop Protection chemistries, Soil & Plant Health products, and Hybrid Seeds. The ‘Others’ segment comprises the legacy polymer business operations.
| Segment Name | FY 2025-26 Revenue (₹ Cr) | % Share of Total Revenue | FY 2024-25 Revenue (₹ Cr) | FY 2025-26 Segment Results / PBIT (₹ Cr) | FY 2025-26 Segment Assets (₹ Cr) | FY 2025-26 Segment Liabilities (₹ Cr) | Latest YoY (%) |
|---|---|---|---|---|---|---|---|
| Agri Inputs | 2,876.13 | 99.30% | 2,629.27 | 217.62 | 2,685.22 | 1,249.20 | +9.39% |
| Others (Polymer, etc.) | 20.52 | 0.70% | 33.67 | 11.12 | 32.72 | 2.93 | -39.06% |
| Unallocated / Corporate | — | — | — | (10.42) | 627.11 | 49.94 | – |
| Total Operating Business | 2,896.65 | 100.00% | 2,662.94 | 218.32 | 3,345.05 | 1,302.07 | +8.78% |
From an internal business vertical perspective, the revenue composition across Crop Care (Domestic B2C, B2B, Exports), Soil & Plant Health, and Seeds breaks down as follows:
- Domestic Crop Protection (B2C & B2B): Revenue reached ₹15.39 crore (B2C ₹ 1,420 crore, B2B ₹ 119 crore), driven by double-digit volume growth in herbicides and non-selective weedicides like Laafa and Glytaf 71.
- Crop Care Exports (B2B & CSM): Revenue expanded by 17.43% to ₹6.40 crore (up from ₹ 545 crore in FY 2024-25), led by strong international demand for active ingredients such as Metribuzin, Hexaconazole, Acephate, and Pendimethalin.
- Soil & Plant Health (SPH): Generated ₹ 237 crore in revenue, driven by biologicals, patented GEOGREEN® organic manure, secondary nutrients, and the newly launched NuCode™ biological platform.
- Seeds Division: Generated ₹48.10 crore in revenue (15.07% growth over ₹4.18 crore in FY 2024-25), recording its third consecutive year of strong performance led by cotton hybrids (Diggaz), paddy, maize, and mustard.
The Product & Service Catalog
Rallis manufactures and distributes a comprehensive portfolio of crop inputs tailored for major agronomic cropping systems including Rice, Cotton, Maize, Wheat, Sugarcane, Pulses, Mustard, and High-Value Horticulture:
- Crop Protection Chemistries: Comprehensive catalogue of Active Ingredients (AIs) and advanced formulations across Fungicides (Hexaconazole, Metalaxyl, Difenoconazole, Kresoxim Methyl, Contaf Plus), Insecticides (Acephate, Acetamiprid, Lambda Cyhalothrin, Tetrachlorovinphos, Blitox, Tafgor), and Herbicides (Metribuzin, Pendimethalin, Pyraflufen-ethyl 2.5% EC). Formulations span Suspension Concentrates (SC), Emulsifiable Concentrates (EC), Water Dispersible Granules (WDG), Capsule Suspensions (CS), and Oil Dispersions (OD).
- Soil & Plant Health (NuCode™ & GEOGREEN®): Science-backed plant nutrition, bio-stimulants, bio-fertilisers, and soil conditioners. Flagship products include GEOGREEN® (India’s only patented and scientifically enriched organic manure), Tata Bahaar, Gluco-Beta, Uphaar, and NAYAZINC™ (zinc-fortified nutrition).
- Hybrid Seeds (‘Dhaanya’ Brand): High-yielding, climate-resilient hybrid germplasm spanning Field Crops (Hybrid Cotton, Hybrid Paddy, Research Variety Paddy, Hybrid Maize, Pearl Millet/Bajra, Mustard, Wheat) and Fodder Crops (Single-cut and Multi-cut fodder).
- Custom Synthesis & Manufacturing (CSM): Process development, scale-up, and dedicated contract manufacturing of complex chemical intermediates, active ingredients, and specialty formulations for global agrochemical innovators.
The Names You Know
The Company owns an extensive intellectual property portfolio anchoring its market visibility. The ‘Dhaanya’ brand serves as Rallis’ flagship seed identity, bridging corporate credibility with high-performing farm inputs. In crop protection, legacy brands like Blitox® and Tafgor® each crossed ₹10.00 crore in annual revenue for the first time in FY 2025-26.
Rallis drives proprietary innovation through its central research hubs: the Rallis Innovation Chemistry Hub (RICH) in Bengaluru (NABL ISO/IEC 17025 accredited for analytical quality control) and the Agri-Biotech Centre in Bengaluru. In FY 2025-26, Rallis was granted 5 new patents (including a novel three-way insecticide combination and differentiated formulations) and filed 11 new patent applications. Key recent product launches include FIPLAM® (a patented ZC formulation for cotton pest management), Alstor® (insecticide combination for rice and sugarcane), and Pyraflufen-ethyl 2.5% EC (India’s first registered cotton defoliant supporting High-Density Planting Systems).
Mapping the Domestic & Global Reach
Rallis maintains a well-balanced geographic distribution, combining a vast domestic distribution ecosystem across India with growing international sales across Asia-Pacific, North America, Latin America, Europe, Africa, and Australia.
| Geographic Market | FY 2025-26 Revenue (₹ Cr) | % Share of Total Revenue | FY 2024-25 Revenue (₹ Cr) | Latest YoY (%) |
|---|---|---|---|---|
| India (Domestic) | 2,303.69 | 79.53% | 2,141.35 | +7.58% |
| Asia (Excluding India) | 290.82 | 10.04% | 213.54 | +36.19% |
| North America | 153.28 | 5.29% | 144.11 | +6.36% |
| Europe | 76.50 | 2.64% | 78.38 | -2.40% |
| South America (LATAM) | 52.74 | 1.82% | 52.19 | +1.05% |
| Africa | 16.12 | 0.56% | 28.82 | -44.07% |
| Australia | 3.50 | 0.12% | 4.55 | -23.08% |
| Total Global Operations | 2,896.65 | 100.00% | 2,662.94 | +8.78% |
The Brick & Mortar Footprint
Rallis operates five state-of-the-art agrochemical chemical synthesis and formulation manufacturing facilities, complemented by dedicated seed drying and processing infrastructure, research stations, and distribution depots:
- Akola Unit (Maharashtra): 26,900 MT per annum formulation capacity; specialized in liquid, granular, and water-soluble fertiliser/bio-stimulant production (Tata Bahaar, Glucobeta).
- Lote Unit (Maharashtra): 10,400 MT per annum technical-grade active ingredient synthesis capacity.
- Ankleshwar Unit (Gujarat): 3,707 MT per annum technical-grade synthesis and formulation capacity; ISO 50001 certified for energy management.
- Dahej Special Economic Zone (SEZ Unit, Gujarat): 12,540 MT per annum technical and formulation capacity, housing a multi-purpose plant (MPP) and automated CSTR nitration systems.
- Dahej Chemical Zone (CZ Unit, Gujarat): 20,550 MT per annum formulation capacity, supported by an on-site 4.4 MWp solar power installation.
- Seed Processing Facilities (Telangana): Automated gas-based wet cob-drying and seed processing facility at Kokkonda (Siddipet District) and GP Pally (Medchal District), Telangana.
- R&D & Breeding Infrastructure: 2 central innovation hubs in Bengaluru (RICH and Agri-Biotech Centre) alongside 13 research stations spread across diverse agro-climatic zones in India.
- Distribution Depot & Channel Network: 28 operating sales depots, 4,662 Crop Care dealers, 2,600 Seeds dealers, and 95,000+ retail connections reaching ~80% of Indian agricultural districts.
📊 The Financial Health: The Numbers Simplified
The multi-year financial trajectory of Rallis India Limited over the past five fiscal years underscores consistent top-line growth, disciplined working capital management, and steady return metrics:
| Financial Metric (₹ Cr) | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | Latest YoY (%) |
|---|---|---|---|---|---|---|
| Revenue from Operations | 2,896.65 | 2,662.94 | 2,648.00 | 2,967.00 | 2,604.00 | +8.78% |
| EBITDA | 360.98 | 287.00 | 311.00 | 218.00 | 274.00 | +25.78% |
| EBITDA Margin (%) | 12.46% | 10.78% | 11.74% | 7.35% | 10.52% | – |
| Profit After Tax (PAT) | 183.88 | 125.13 | 148.00 | 92.00 | 164.00 | +46.95% |
| PAT Margin (%) | 6.35% | 4.70% | 5.59% | 3.10% | 6.30% | – |
| Basic EPS (₹) | 9.46 | 6.43 | 7.61 | 4.73 | 8.44 | +47.12% |
| Total Equity / Net Worth | 2,042.97 | 1,904.25 | 1,829.00 | 1,730.00 | 1,697.00 | +7.28% |
| Return on Equity (ROE) (%) | 9.00% | 6.57% | 8.00% | 5.00% | 10.00% | – |
| Return on Capital Employed (ROCE) (%) | 11.50% | 8.30% | 11.00% | 7.00% | 13.00% | – |
Earnings, Expenses, & Take-Home Profits
In FY 2025-26, Rallis reported a robust financial performance driven by volume expansion across domestic crop protection, export markets, and seeds. Total Income reached ₹ 2,939.36 crore, while Profit Before Tax (PBT) expanded by 34.09% to ₹ 250.30 crore despite an exceptional charge of ₹ 26.23 crore relating to past service gratuity adjustments following the Labour Code reassessment.
| Statement of Profit and Loss (Line Item) | FY 2025-26 (₹ Cr) | FY 2024-25 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| I. Revenue from Operations | 2,896.65 | 2,662.94 | +8.78% |
| II. Other Income | 42.71 | 31.72 | +34.65% |
| III. Total Income (I + II) | 2,939.36 | 2,694.66 | +9.08% |
| Cost of materials consumed | 1,579.17 | 1,301.55 | +21.33% |
| Purchases of stock-in-trade | 273.17 | 230.79 | +18.36% |
| Changes in inventories of finished goods, WIP and stock-in-trade | (124.71) | 48.49 | N/M |
| Employee benefits expense | 283.12 | 274.79 | +3.03% |
| Finance costs | 10.32 | 12.49 | -17.37% |
| Depreciation and amortisation expenses | 117.13 | 120.49 | -2.79% |
| Other expenses | 524.63 | 520.56 | +0.78% |
| IV. Total Expenses | 2,662.83 | 2,509.16 | +6.12% |
| V. Profit Before Exceptional Items and Tax (III – IV) | 276.53 | 185.50 | +49.07% |
| VI. Exceptional Items (Gratuity & Impairment adjustments) | (26.23) | 1.17 | N/M |
| VII. Profit Before Tax (V + VI) | 250.30 | 186.67 | +34.09% |
| Current tax expense | 79.25 | 55.57 | +42.61% |
| Deferred tax charge / (credit) | (12.83) | 5.97 | N/M |
| Total Tax Expense | 66.42 | 61.54 | +7.93% |
| VIII. Profit After Tax for the Year (VII – Tax) | 183.88 | 125.13 | +46.95% |
| Remeasurement of employee defined benefit plans (net of tax) | 3.46 | (1.75) | N/M |
| IX. Total Comprehensive Income for the Year | 187.34 | 123.38 | +51.84% |
| Basic & Diluted Earnings Per Share (Face Value ₹ 1) | 9.46 | 6.43 | +47.12% |
Assets, Borrowings, & Net Worth
Rallis maintains an exceptionally sound balance sheet structure. As of March 31, 2026, Total Assets stood at ₹ 3,345.05 crore, backed by ₹ 2,042.97 crore in Total Equity. The Company’s debt profile consists primarily of interest-free sales tax deferral loans (₹ 0.61 crore total) and short-term working capital borrowings of ₹ 6.29 crore, offset by liquid treasury mutual fund holdings of ₹ 501.78 crore and cash balances of ₹ 45.43 crore.
| Balance Sheet Line Item | As at March 31, 2026 (₹ Cr) | As at March 31, 2025 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| Property, plant and equipment | 579.69 | 622.72 | -6.91% |
| Capital work-in-progress (CWIP) | 10.69 | 24.88 | -57.03% |
| Investment property | 0.73 | 1.17 | -37.61% |
| Right-of-use assets | 47.79 | 56.60 | -15.57% |
| Goodwill on amalgamation | 195.82 | 195.82 | 0.00% |
| Other intangible assets | 25.35 | 27.31 | -7.18% |
| Intangible assets under development | 21.55 | 27.33 | -21.15% |
| Non-current financial assets (Investments & Deposits) | 14.81 | 19.97 | -25.84% |
| Non-current tax assets (net) & Deferred tax assets | 103.23 | 97.69 | +5.67% |
| Other non-current assets | 36.22 | 35.47 | +2.11% |
| Total Non-Current Assets | 1,035.88 | 1,108.96 | -6.59% |
| Inventories | 959.11 | 750.97 | +27.72% |
| Current investments (Mutual Funds – FVTPL) | 501.78 | 408.12 | +22.95% |
| Trade receivables | 615.68 | 541.43 | +13.71% |
| Cash and cash equivalents & Bank balances | 45.43 | 31.17 | +45.75% |
| Other current financial assets | 9.58 | 14.01 | -31.62% |
| Other current assets & Assets held for sale | 177.59 | 119.83 | +48.20% |
| Total Current Assets | 2,309.17 | 1,865.53 | +23.78% |
| TOTAL ASSETS | 3,345.05 | 2,974.49 | +12.46% |
| Equity Share Capital | 19.45 | 19.45 | 0.00% |
| Other Equity (Reserves & Surplus) | 2,023.52 | 1,884.80 | +7.36% |
| Total Equity (Net Worth) | 2,042.97 | 1,904.25 | +7.28% |
| Non-current borrowings (Sales tax deferral) | 0.14 | 0.61 | -77.05% |
| Non-current lease liabilities | 45.20 | 49.87 | -9.36% |
| Non-current provisions & Deferred tax liabilities | 32.42 | 51.02 | -36.46% |
| Total Non-Current Liabilities | 77.76 | 101.50 | -23.39% |
| Current borrowings (Short-term loans & Current maturity) | 6.76 | 0.47 | +1338.30% |
| Current lease liabilities | 9.00 | 12.15 | -25.93% |
| Trade payables (MSME: ₹ 23.69 Cr | Others: ₹ 703.78 Cr) | 727.47 | 541.16 | +34.43% |
| Other current financial liabilities | 188.24 | 173.09 | +8.75% |
| Other current liabilities, Provisions & Tax liabilities | 292.85 | 241.87 | +21.08% |
| Total Current Liabilities | 1,224.32 | 968.74 | +26.38% |
| TOTAL EQUITY AND LIABILITIES | 3,345.05 | 2,974.49 | +12.46% |
Cash Flow: Tracking the Money Movement
Rallis generated ₹ 172.11 crore in Net Cash from Operating Activities in FY 2025-26, supported by robust cash conversion from operating profit before working capital changes (₹ 375.06 crore). Working capital adjustments reflected inventory deployment for the upcoming kharif season (₹ 207.79 crore build-up) offset by trade payable expansion (₹ 183.87 crore).
| Statement of Cash Flows (Summary) | FY 2025-26 (₹ Cr) | FY 2024-25 (₹ Cr) | Latest YoY (%) |
|---|---|---|---|
| Operating Profit Before Working Capital Changes | 375.06 | 316.97 | +18.33% |
| Working capital adjustments (Inventories, Receivables, Payables) | (134.50) | 32.91 | N/M |
| Direct taxes paid (net of refunds) | (68.45) | (54.77) | +24.98% |
| Net Cash Generated from Operating Activities (A) | 172.11 | 295.11 | -41.68% |
| Purchase of property, plant, equipment & intangibles (CapEx) | 44.67 | 73.41 | -39.15% |
| Net purchase / sale of current mutual fund investments | (66.04) | (143.70) | -54.04% |
| Proceeds from disposal of PPE / assets held for sale & interest/div. | 11.50% | 8.30% | – |
| Net Cash Used in Investing Activities (B) | (94.88) | (213.81) | -55.62% |
| Repayment / proceeds of borrowings (net) | 11.50% | 8.30% | – |
| Payment of lease liabilities | (18.25) | (24.48) | -25.45% |
| Dividend paid on equity shares | (48.58) | (48.55) | +0.06% |
| Interest and finance costs paid | (5.15) | (6.59) | -21.85% |
| Net Cash Used in Financing Activities (C) | (66.16) | (80.09) | -17.39% |
| Net Increase in Cash and Cash Equivalents (A + B + C) | 11.07 | 1.21 | +814.88% |
| Cash and Cash Equivalents at Beginning of Year | 27.86 | 26.65 | +4.54% |
| Cash and Cash Equivalents at End of Year | 38.93 | 27.86 | +39.73% |
Funding the Future: CapEx, CWIP & R&D Spending
Rallis continues to invest heavily in scientific research and manufacturing modernization. Total R&D expenditure for FY 2025-26 stood at ₹ 66.01 crore (representing 2.28% of revenue from operations), comprising ₹0.64 crore in revenue expenditure and ₹ 2.20 crore in capital expenditure across its innovation chemistry and agri-biotech hubs.
Capital expenditure additions to Property, Plant, and Equipment totalled ₹ 40.58 crore during the year, with major projects spanning the commissioning of the water-soluble fertiliser/bio-stimulant unit at Akola, CSTR nitration systems at the Dahej SEZ Pendimethalin plant (₹ 14.83 crore capital outlay), and energy efficiency upgrades across Lote and Ankleshwar. Capital Work-in-Progress (CWIP) as of March 31, 2026 stood at ₹ 10.69 crore (down from ₹ 24.88 crore in FY 2024-25 following the capitalisation of ₹ 51.69 crore into active assets during the year).
🗺️ The Corporate Family Tree: Structure & Investments
Subsidiaries, Associates, & Joint Ventures (Form AOC-1)
As explicitly disclosed in the Board’s Report, Rallis India Limited has no subsidiaries, associate companies, or joint venture entities as of March 31, 2026. Following the full legal merger and amalgamation of its former subsidiaries—Metahelix Life Sciences Limited and Zero Waste Agro Organics Limited—into the parent company in previous reporting periods, all business operations are executed directly under Rallis India Limited. Consequently, Form AOC-1 under Section 129(3) of the Companies Act, 2013 is not applicable, and the Company is not required to prepare consolidated financial statements.
Strategic Investments & Treasury Holdings
Rallis maintains a conservative treasury policy alongside strategic minority investments in infrastructure and industry-enabling entities:
- Treasury Mutual Fund Investments: Current investments carried at Fair Value Through Profit and Loss (FVTPL) totalled ₹ 501.78 crore as of March 31, 2026 (up from ₹ 408.12 crore in FY 2024-25), consisting of liquid mutual fund schemes managed to ensure capital preservation and liquidity.
- Strategic Equity Holdings (FVTOCI): Unquoted strategic equity holdings carried at Fair Value Through Other Comprehensive Income total ₹ 3.59 crore. Key investments include Impetis Biosciences Ltd. (₹ 3.17 crore), Narmada Clean Tech Ltd. (₹ 0.30 crore), Biotech Consortium India Ltd. (₹ 0.05 crore), Bharuch Enviro Infrastructure Ltd. (₹ 0.04 crore), and Indian Potash Ltd. (₹ 0.02 crore). Quoted equity holdings stand at ₹ 0.02 crore (J.K. Cement Ltd.).
👥 Power & Control: Who Pulls the Strings?
The Brain Trust: Board of Directors & Key Managerial Personnel (KMP)
The Board of Directors of Rallis India Limited comprises nine eminent corporate leaders and industry experts, maintaining an optimal balance of Independent, Executive, and Non-Executive representation:
| Name of Director / KMP | Designation / Category | Director Identification Number (DIN) | Board Committees Membership / Chairmanship |
|---|---|---|---|
| S. Padmanabhan | Chairman & Non-Executive, Non-Independent Director | 00306299 | Chairman – Executive Committee of the Board |
| Dr. Gyanendra Shukla | Managing Director & CEO (Executive) | 02922133 | Member – CSR, RMC, SHES, Executive Committee |
| R. Mukundan | Non-Executive, Non-Independent Director (MD & CEO, Tata Chemicals) | 00778253 | Member – Audit, NRC, SRC |
| Dr. C. V. Natraj | Non-Executive, Independent Director | 07132764 | Chairman – NRC, SRC, CSR, SHES; Member – Audit |
| Padmini Khare Kaicker | Non-Executive, Independent Director | 00296388 | Chairperson – Audit, RMC; Member – NRC |
| Mahesh Kumar Girdhar | Non-Executive, Independent Director (w.e.f. Dec 10, 2025) | 10270848 | Member – Audit, CSR, SHES |
| Ashok Hiralal Sharma | Non-Executive, Independent Director (w.e.f. Feb 10, 2026) | 02766679 | Member – Board of Directors |
| Rashmi Joshi | Additional Independent Director (Effective April 3, 2026) | 06641898 | Member – Board of Directors |
| David Francis Crean | Additional Independent Director (Effective April 27, 2026) | 09584874 | Member – Board of Directors |
| Bhaskar Swaminathan | Chief Financial Officer (KMP w.e.f. Aug 7, 2025) | N.A. (KMP) | Member – Risk Management Committee |
| Sariga P. Gokul | Company Secretary & Compliance Officer (KMP w.e.f. May 9, 2025) | N.A. (KMP) | Secretary to all Board Committees |
Who Owns the Stock? Shareholding Pattern
Rallis has a total paid-up equity share capital of ₹ 19.45 crore, divided into 19,44,68,890 equity shares of face value ₹ 1 each. The shareholding structure as of March 31, 2026 exhibits strong promoter stability led by the Tata Group:
| Shareholder Category | Number of Equity Shares Held | % Shareholding as on March 31, 2026 |
|---|---|---|
| Promoter & Promoter Group | 10,71,16,610 | 55.08% |
| Tata Chemicals Limited (Holding Company) | 10,70,41,610 | 55.04% |
| Ewart Investments Limited (Promoter Group) | 75,000 | 0.04% |
| Domestic Institutional Investors (DIIs) | 2,68,00,610 | 13.79% |
| Mutual Funds (SBI Mutual Fund holds 9.43% / 1,83,33,693 shares) | 1,93,86,656 | 9.97% |
| Banks, Insurance & Financial Institutions | 29,37,376 | 1.51% |
| Alternative Investment Funds (AIFs) | 4,76,575 | 0.24% |
| Other Corporate Bodies & Trusts | 40,22,604 | 2.07% |
| Foreign Institutional Investors (FIIs / FPIs & NRIs) | 2,46,66,151 | 12.68% |
| Foreign Institutional Investors / Foreign Companies | 2,24,57,909 | 11.55% |
| Non-Resident Individuals (NRIs) | 22,08,242 | 1.14% |
| Public Retail Shareholders (Resident Individuals) | 3,49,32,307 | 17.96% |
| Investor Education and Protection Fund (IEPF) | 9,53,212 | 0.49% |
| Total Equity Capital | 19,44,68,890 | 100.00% |
🎯 The Strategic Outlook: Future Plans & Potential Pitfalls
Competitive Advantages & Economic Moats
Rallis possesses structural competitive advantages anchored in its deep rural distribution reach, integrated synthesis-to-formulation infrastructure, and the institutional backing of the Tata Group:
- Pan-India Agronomic & Channel Reach: Coverage across 26 Indian States and UTs reaching 80% of agricultural districts, backed by 4,662 Crop Care dealers, 2,600 Seeds dealers, and 95,000+ retail touchpoints.
- Integrated Chemistry & Seeds R&D: Dual research engine comprising RICH (chemistry innovation) and the Agri-Biotech Centre (plant genetics, speed breeding, doubled haploidy) supported by 13 regional research stations.
- Scale Manufacturing & Global EHS Benchmarks: Five chemical synthesis and formulation facilities operating under ISO 9001, ISO 14001, ISO 45001, ISO 50001, and Responsible Care® standards, providing significant cost competitiveness for international B2B and CSM operations.
- Tata Group Synergies & Capital Structure: Zero net debt balance sheet and strong working capital discipline providing total capital allocation flexibility for high-return CapEx and technology acquisitions.
What Could Go Wrong? Key Challenges & Business Risks
Management actively tracks and mitigates key enterprise risks inherent to the agri-inputs sector:
- Climate Variability & Monsoonal Dependency: Erratic monsoon distribution, flood/drought cycles, or unseasonal temperature spikes during critical kharif/rabi sowing windows directly impact product demand and trigger elevated sales returns.
- Global Supply Overhang & Price Volatility: Resumption of aggressive generic agrochemical exports from China and global price deflation across technical active ingredients pressure operating margins in catalogue exports.
- Regulatory & Label Compliance Risks: Tightening registration requirements under the Central Insecticides Board & Registration Committee (CIB-RC) and changing Fertiliser Control Order (FCO) norms for bio-stimulants require continuous regulatory adaptation.
- Unauthorised Seed Proliferation: Illegal cultivation of unapproved Herbicide-Tolerant (HT) cotton varieties in Central/Western India impacts legitimate selective herbicide sales and proprietary seed adoption.
The Next Chapter: Growth & CapEx Initiatives
Rallis’ medium-term strategic roadmap focuses on five key transformation pillars:
- Biologicals & Regenerative Agriculture Scale-Up: Accelerating commercial execution under the NuCode™ biological platform, expanding in-house bio-stimulant manufacturing at the Akola plant, and advancing the FullPage® Herbicide Tolerance Rice Technology partnership with Paryan Alliance for Direct Seeded Rice (DSR).
- Catalogue Expansion & Multipurpose Plant (MPP) Utilization: Scaling up production across newly commercialized technical molecules (including Pyraflufen-ethyl, Metribuzin, and Pendimethalin) at the Dahej SEZ MPP facility to drive international B2B expansion.
- Breeding Acceleration in Core Seeds: Deploying molecular breeding, doubled haploidy, and machine learning tools (SeedSay) to shorten hybrid development cycles by up to two years across Rice, Cotton, Maize, Bajra, and Mustard under the ‘Launch Big and Scale Fast’ (LBSF) framework.
- Open Innovation via Idea2Impact™: Partnering with agtech startups, research institutions (IARI, IRRI, IIRR), and universities to co-create scalable solutions in climate-resilient traits, precision agriculture, and low-residue chemistries.
- Project Sunshine & Sustainability Goals: Advancing the “30 by 30” carbon abatement plan (30% absolute emissions reduction by 2030) through the installation of a 3,500 kWp solar power plant at Bardoli to power Ankleshwar operations, targeting 100% Zero Liquid Discharge (ZLD) capability across all manufacturing sites.
The Verdict: Strategic Outlook & Conclusion
With an established 77-year legacy, zero external net debt, a robust R&D pipeline, and strong execution capabilities across Crop Care, Biologicals, and Seeds, Rallis India Limited is uniquely positioned to capitalize on the structural modernization of Indian agriculture. By combining science-led innovation with the Tata Group’s unwavering commitment to corporate governance and sustainability, Rallis continues to deliver enduring value for Indian farming communities and global business partners alike.
Note: Financial ratios, margins, YoY growth percentages, and % revenue shares are calculated by IndianCompanies.in based on disclosed Ind AS financial statements.
Official Site: https://www.rallis.com